These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 21771877)

  • 21. Prospective evaluation of 64 serum autoantibodies as biomarkers for early detection of colorectal cancer in a true screening setting.
    Chen H; Werner S; Butt J; Zörnig I; Knebel P; Michel A; Eichmüller SB; Jäger D; Waterboer T; Pawlita M; Brenner H
    Oncotarget; 2016 Mar; 7(13):16420-32. PubMed ID: 26909861
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of a new panel of serum autoantibodies associated with the presence of in situ carcinoma of the breast in younger women.
    Desmetz C; Bascoul-Mollevi C; Rochaix P; Lamy PJ; Kramar A; Rouanet P; Maudelonde T; Mangé A; Solassol J
    Clin Cancer Res; 2009 Jul; 15(14):4733-41. PubMed ID: 19584157
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel serum nucleosomics biomarkers for the detection of colorectal cancer.
    Holdenrieder S; Dharuman Y; Standop J; Trimpop N; Herzog M; Hettwer K; Simon K; Uhlig S; Micallef J
    Anticancer Res; 2014 May; 34(5):2357-62. PubMed ID: 24778043
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantitative real-time RT-PCR detection for survivin, CK20 and CEA in peripheral blood of colorectal cancer patients.
    Shen C; Hu L; Xia L; Li Y
    Jpn J Clin Oncol; 2008 Nov; 38(11):770-6. PubMed ID: 18845519
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of a multiplexed tumor-associated autoantibody-based blood test for the detection of colorectal cancer.
    Fan CW; Kuo YB; Lin GP; Chen SM; Chang SH; Li BA; Chan EC
    Clin Chim Acta; 2017 Dec; 475():157-163. PubMed ID: 29074220
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum proteomic profiling for the early diagnosis of colorectal cancer.
    Zhu D; Wang J; Ren L; Li Y; Xu B; Wei Y; Zhong Y; Yu X; Zhai S; Xu J; Qin X
    J Cell Biochem; 2013 Feb; 114(2):448-55. PubMed ID: 22961748
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Value of tumor markers in diagnosing and monitoring colorectal cancer and strategies for further improvement: analysis of 130 cases.
    Chen C; Chen LQ; Yang GL; Li Y
    Ai Zheng; 2007 Nov; 26(11):1221-6. PubMed ID: 17991322
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic significance of multiple molecular markers for patients with stage II colorectal cancer undergoing curative resection.
    Uen YH; Lin SR; Wu DC; Su YC; Wu JY; Cheng TL; Chi CW; Wang JY
    Ann Surg; 2007 Dec; 246(6):1040-6. PubMed ID: 18043108
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical significance of circulating galectins as colorectal cancer markers.
    Watanabe M; Takemasa I; Kaneko N; Yokoyama Y; Matsuo E; Iwasa S; Mori M; Matsuura N; Monden M; Nishimura O
    Oncol Rep; 2011 May; 25(5):1217-26. PubMed ID: 21369702
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patients with sporadic colorectal cancer or advanced adenomatous polyp have elevated anti-JC virus antibody titer in comparison with healthy controls: a cross-sectional study.
    Niv Y; Vilkin A; Levi Z
    J Clin Gastroenterol; 2010 Aug; 44(7):489-94. PubMed ID: 20421810
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Utility of serum preoperative carcinoemberyonic antigen in colorectal cancer patients.
    El-Awady S; Lithy R; Morshed M; Khafagy W; Abd Monem H; Waleed O; Badr S; Fekry A; El Nakeeb A; Ghazy H; El Yamany M; Metwally T; El-Arman M; Farid M
    Hepatogastroenterology; 2009; 56(90):361-6. PubMed ID: 19579599
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutant p53 protein in the serum of patients with colorectal cancer: Correlation with the level of carcinoembryonic antigen and serum epidermal growth factor receptor.
    Abdel-Aziz MM; Lotfy M; El-Kady IM; Abozaid M
    Cancer Detect Prev; 2009; 32(4):329-35. PubMed ID: 16632243
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular detection of circulating cancer cells in the peripheral blood of patients with colorectal cancer by using membrane array with a multiple mRNA marker panel.
    Yeh CS; Wang JY; Wu CH; Chong IW; Chung FY; Wang YH; Yu YP; Lin SR
    Int J Oncol; 2006 Feb; 28(2):411-20. PubMed ID: 16391796
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serrated carcinomas form a subclass of colorectal cancer with distinct molecular basis.
    Laiho P; Kokko A; Vanharanta S; Salovaara R; Sammalkorpi H; Järvinen H; Mecklin JP; Karttunen TJ; Tuppurainen K; Davalos V; Schwartz S; Arango D; Mäkinen MJ; Aaltonen LA
    Oncogene; 2007 Jan; 26(2):312-20. PubMed ID: 16819509
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combined analysis of survivin autoantibody and carcinoembryonic antigen biomarkers for improved detection of colorectal cancer.
    Chen JS; Chen KT; Fan WC; Yu JS; Chang YS; Chan EC
    Clin Chem Lab Med; 2010 May; 48(5):719-25. PubMed ID: 20178447
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aberrant methylation of APC, MGMT, RASSF2A, and Wif-1 genes in plasma as a biomarker for early detection of colorectal cancer.
    Lee BB; Lee EJ; Jung EH; Chun HK; Chang DK; Song SY; Park J; Kim DH
    Clin Cancer Res; 2009 Oct; 15(19):6185-91. PubMed ID: 19773381
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An integrated proteomics and metabolomics approach for defining oncofetal biomarkers in the colorectal cancer.
    Ma Y; Zhang P; Wang F; Liu W; Yang J; Qin H
    Ann Surg; 2012 Apr; 255(4):720-30. PubMed ID: 22395091
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adiponectin levels in patients with colorectal cancer and adenoma: a meta-analysis.
    An W; Bai Y; Deng SX; Gao J; Ben QW; Cai QC; Zhang HG; Li ZS
    Eur J Cancer Prev; 2012 Mar; 21(2):126-33. PubMed ID: 21960184
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification and validation of a blood-based 18-gene expression signature in colorectal cancer.
    Xu Y; Xu Q; Yang L; Ye X; Liu F; Wu F; Ni S; Tan C; Cai G; Meng X; Cai S; Du X
    Clin Cancer Res; 2013 Jun; 19(11):3039-49. PubMed ID: 23536436
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical study of autoantibody spectrum against ovarian cancer associated antigens combined with CA(125) in detecting and monitoring ovarian cancer].
    Yang ZJ; Yang G; Jiang YM; Ran YL; Yang ZH; Zhang W; Zhang JQ; Pan ZM; Li L
    Zhonghua Fu Chan Ke Za Zhi; 2011 Feb; 46(2):113-8. PubMed ID: 21426769
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.